Frontiers in Cell and Developmental Biology (Feb 2022)

Identification of DDX31 as a Potential Oncogene of Invasive Metastasis and Proliferation in PDAC

  • Yongjie Xie,
  • Yongjie Xie,
  • Yang Liu,
  • Yang Liu,
  • Jinsheng Ding,
  • Jinsheng Ding,
  • Guangming Li,
  • Bo Ni,
  • Bo Ni,
  • Huifang Pang,
  • Xin Hu,
  • Liangliang Wu,
  • Liangliang Wu

DOI
https://doi.org/10.3389/fcell.2022.762372
Journal volume & issue
Vol. 10

Abstract

Read online

Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignant tumors worldwide and has poor prognosis. DEAD box proteins31 (DDX31) participate in cellular processes involving RNA secondary structure changes. However, the functions of DDX31 in PDAC remain to be elucidated.Methods: The key gene DDX31 was identified using a combination of a risk model and weighted gene co-expression network analysis (WGCNA) with R software. The biological functions of DDX31 in PDAC were investigated through bioinformatics analysis and in vitro experiments.Results: Combining with WGCNA and risk model, DDX31 was identified as a potential factor of the invasive metastasis properties of PDAC, and its expression was closely related to the malignant differentiation of PDAC. The results of gene set enrichment analysis (GSEA) showed that DDX31 was correlated with cell invasive metastasis and proliferation by activating MAPK signaling pathway. The inhibition of DDX31 inhibited the invasion and migration of PDAC cells. Survival analysis showed that DDX31 expression was negatively associated with the poor prognosis in patients with PDAC.Interpretation:DDX31 may be a potential factor for PDAC. The inhibition of DDX31 may be a potential way to treat PDAC.

Keywords